|
1
|
Colombo N, Carinelli S, Colombo A, Marini
C, Rollo D and Sessa C; ESMO Guidelines Working Group, : Cervical
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 23 Suppl 7:vii27–vii32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeung TL, Leung CS, Yip KP, Au Yeung CL,
Wong ST and Mok SC: Cellular and molecular processes in ovarian
cancer metastasis. A Review in the Theme: Cell and molecular
processes in cancer metastasis. Am J Physiol Cell Physiol.
309:C444–C456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi JF, Canfell K, Lew JB and Qiao YL: The
burden of cervical cancer in China: Synthesis of the evidence. Int
J Cancer. 130:641–652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warzecha CC, Sato TK, Nabet B, Hogenesch
JB and Carstens RP: ESRP1 and ESRP2 are epithelial
cell-type-specific regulators of FGFR2 splicing. Mol Cell.
33:591–601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Degrauwe N, Suva ML, Janiszewska M, Riggi
N and Stamenkovic I: IMPs: An RNA-binding protein family that
provides a link between stem cell maintenance in normal development
and cancer. Genes & development. 30:2459–2474. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katz Y, Li F, Lambert NJ, Sokol ES, Tam
WL, Cheng AW, Airoldi EM, Lengner CJ, Gupta PB, Yu Z, et al:
Musashi proteins are post-transcriptional regulators of the
epithelial-luminal cell state. eLife. 3:e039152014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Horisawa K, Imai T, Okano H and Yanagawa
H: The Musashi family RNA-binding proteins in stem cells.
Biomolecular concepts. 1:59–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park SM, Deering RP, Lu Y, Tivnan P,
Lianoglou S, Al-Shahrour F, Ebert BL, Hacohen N, Leslie C, Daley
GQ, et al: Musashi-2 controls cell fate, lineage bias and TGF-beta
signaling in HSCs. J Exp Med. 211:71–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hope KJ, Cellot S, Ting SB, MacRae T,
Mayotte N, Iscove NN and Sauvageau G: An RNAi screen identifies
Msi2 and Prox1 as having opposite roles in the regulation of
hematopoietic stem cell activity. Cell Stem Cell. 7:101–113. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kharas MG, Lengner CJ, Al-Shahrour F,
Bullinger L, Ball B, Zaidi S, Morgan K, Tam W, Paktinat M, Okabe R,
et al: Musashi-2 regulates normal hematopoiesis and promotes
aggressive myeloid leukemia. Nat Med. 16:903–908. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang MH, Qin SY, Zhang SG, Li GX, Yu ZH,
Wang K, Wang B, Teng MJ and Peng ZH: Musashi-2 promotes hepatitis B
virus related hepatocellular carcinoma progression via the
Wnt/β-catenin pathway. Am J Cancer Res. 5:1089–1100.
2015.PubMed/NCBI
|
|
12
|
Barbouti A, Höglund M, Johansson B, Lassen
C, Nilsson PG, Hagemeijer A, Mitelman F and Fioretos T: A novel
gene, MSI2, encoding a putative RNA-binding protein is recurrently
rearranged at disease progression of chronic myeloid leukemia and
forms a fusion gene with HOXA9 as a result of the cryptic
t(7;17)(p15;q23). Cancer Res. 63:1202–1206. 2003.PubMed/NCBI
|
|
13
|
Kudinov AE, Deneka A, Nikonova AS, Beck
TN, Ahn YH, Liu X, Martinez CF, Schultz FA, Reynolds S, Yang DH, et
al: Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins
to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl
Acad Sci USA. 113:pp. 6955–6960. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix and, endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakakibara S, Nakamura Y, Yoshida T,
Shibata S, Koike M, Takano H, Ueda S, Uchiyama Y, Noda T and Okano
H: RNA-binding protein Musashi family: Roles for CNS stem cells and
a subpopulation of ependymal cells revealed by targeted disruption
and antisense ablation. Proc Natl Acad Sci USA. 99:pp. 15194–15199.
2002; View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moreira AL, Gonen M, Rekhtman N and Downey
RJ: Progenitor stem cell marker expression by pulmonary carcinomas.
Mod Pathol. 23:889–895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Emadi-Baygi M, Nikpour P, Mohammad-Hashem
F, Maracy MR and Haghjooy-Javanmard S: MSI2 expression is decreased
in grade II of gastric carcinoma. Pathol Res Pract. 209:689–691.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He L, Zhou X, Qu C, Hu L, Tang Y, Zhang Q,
Liang M and Hong J: Musashi2 predicts poor prognosis and invasion
in hepatocellular carcinoma by driving epithelial-mesenchymal
transition. J Cell Mol Med. 18:49–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaeda J, Ringel F, Oberender C, Mills K,
Quintarelli C, Pane F, Koschmieder S, Slany R, Schwarzer R, Saglio
G, et al: Up-regulated MSI2 is associated with more aggressive
chronic myeloid leukemia. Leuk Lymphoma. 56:2105–2113. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang C, Zhang W, Wang L, Kazobinka G, Han
X, Li B and Hou T: Musashi-2 promotes migration and invasion in
bladder cancer via activation of the JAK2/STAT3 pathway. Lab
Invest. 96:950–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wuebben EL, Mallanna SK, Cox JL and
Rizzino A: Musashi2 is required for the self-renewal and
pluripotency of embryonic stem cells. PLoS One. 7:e348272012.
View Article : Google Scholar : PubMed/NCBI
|
